Glycadia, Inc. is a clinical-stage biopharmaceutical company developing therapeutics for the prevention and treatment of vascular complications of diabetes.
Glycadia, Inc. is a clinical-stage biopharmaceutical company developing therapeutics for the prevention and treatment of vascular complications of diabetes.